| Year |
Citation |
Score |
| 2020 |
Hall JA, Rusten M, Abughazaleh RD, Wuertz B, Souksavong V, Escher P, Ondrey F. Effects of PPAR-γ agonists on oral cancer cell lines: Potential horizons for chemopreventives and adjunctive therapies. Head & Neck. PMID 32519370 DOI: 10.1002/Hed.26286 |
0.412 |
|
| 2020 |
Rosas R, Buryska S, Silver R, Wuertz B, Ondrey F. Retinoids Augment Thiazolidinedione PPARγ Activation in Oral Cancer Cells. Anticancer Research. 40: 3071-3080. PMID 32487601 DOI: 10.21873/Anticanres.14288 |
0.384 |
|
| 2020 |
Swenson DK, Wuertz BR, Ali MM, Unger GM, Ondrey FG. Abstract 23: Precision medicine approaches to Fanconi anemia oral cancer personalized prevention and treatment Cancer Research. 80: 23-23. DOI: 10.1158/1538-7445.Am2020-23 |
0.421 |
|
| 2019 |
Ondrey FG. Pioglitazone, Nuclear Receptors, and Aerodigestive Prevention. Cancer Prevention Research (Philadelphia, Pa.). 12: 641-644. PMID 31537582 DOI: 10.1158/1940-6207.Capr-19-0341 |
0.337 |
|
| 2019 |
Galbraith AR, Seabloom DE, Wuertz BR, Antonides JD, Steele VE, Wattenberg LW, Ondrey FG. Chemoprevention of lung carcinogenesis by dietary nicotinamide and inhaled budesonide. Cancer Prevention Research (Philadelphia, Pa.). PMID 30606719 DOI: 10.1158/1940-6207.Capr-17-0402 |
0.343 |
|
| 2018 |
Miller WA, Wuertz BR, Ondrey FG. PPARγ-Mediated p21 Induction in Aerodigestive Preneoplastic Cell Lines. The Annals of Otology, Rhinology, and Laryngology. 3489418787833. PMID 30047791 DOI: 10.1177/0003489418787833 |
0.378 |
|
| 2018 |
Miller KA, Wuertz BR, Haynes AM, Potter DA, Ondrey FG. Abstract LB-171: Potential chemopreventative treatments in Fanconi anemia related HNSCC Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-171 |
0.434 |
|
| 2018 |
Gutkind JS, Ondrey FG, Laronde D, Rosin M, Molinolo AA, Coffey C, Wuertz BR, Rock LD, Huynh H, Chow HS, Butler VD, Lippman SM, Szabo E. Abstract 4985: M4OC-Prevent: Clinical evaluation of metformin for oral cancer precision prevention Cancer Research. 78: 4985-4985. DOI: 10.1158/1538-7445.Am2018-4985 |
0.41 |
|
| 2017 |
Wuertz BR, Darrah L, Wudel J, Ondrey FG. Thiazolidinediones abrogate cervical cancer growth. Experimental Cell Research. PMID 28219679 DOI: 10.1016/J.Yexcr.2017.02.020 |
0.406 |
|
| 2017 |
Seabloom DE, Galbraith AR, Haynes AM, Antonides JD, Wuertz BR, Miller WA, Miller KA, Steele VE, Miller MS, Clapper ML, O'Sullivan MG, Ondrey FG. Fixed-dose combinations of pioglitazone and metformin for lung cancer prevention. Cancer Prevention Research (Philadelphia, Pa.). PMID 28052934 DOI: 10.1158/1940-6207.Capr-16-0232 |
0.35 |
|
| 2016 |
Seabloom DE, Galbraith AR, Haynes AM, Antonides JD, Wuertz BR, Miller WA, Miller KA, Steele VE, Suen C, O'Sullivan MG, Ondrey FG. Safety and preclinical efficacy of aerosol pioglitazone on lung adenoma prevention in A/J mice. Cancer Prevention Research (Philadelphia, Pa.). PMID 27993834 DOI: 10.1158/1940-6207.Capr-16-0174 |
0.316 |
|
| 2016 |
Handley N, Eide J, Taylor R, Wuertz B, Gaffney P, Ondrey F. PPARγ targeted oral cancer treatment and additional utility of genomics analytic techniques. The Laryngoscope. PMID 27896820 DOI: 10.1002/Lary.26423 |
0.416 |
|
| 2016 |
Wright SK, Wuertz BR, Harris G, Abu Ghazallah R, Miller WA, Gaffney PM, Ondrey FG. Functional activation of PPARγ in human upper aerodigestive cancer cell lines. Molecular Carcinogenesis. PMID 26999671 DOI: 10.1002/Mc.22479 |
0.696 |
|
| 2016 |
Diaz J, Wuertz B, Galbraith A, Ondrey FG. Abstract 2611: Effects of chalcones, nicotinamide, and resveratrol on PPAR gamma activation in oral cancer cells Cancer Research. 76: 2611-2611. DOI: 10.1158/1538-7445.Am2016-2611 |
0.392 |
|
| 2015 |
Seabloom D, Galbraith A, Wuertz B, Haynes A, Miller MS, Steele V, Wattenberg L, Ondrey FG. Abstract LB-264: Effects of dietary metformin/pioglitazone on lung adenoma formation in A/J mice Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-264 |
0.358 |
|
| 2015 |
Miller K, Wuertz B, Ondrey FG. Abstract 914: Pioglitazone and metformin as potential chemopreventative treatments in Fanconi anemia related oral squamous carcinoma Cancer Research. 75: 914-914. DOI: 10.1158/1538-7445.Am2015-914 |
0.446 |
|
| 2014 |
Caicedo-Granados E, Galbraith AR, Schachern MG, Hartle DE, Wattenberg LW, Wuertz BR, Keel S, Yueh B, Ondrey FG. N-methylnitrosourea–induced carcinoma as a model for laryngeal carcinogenesis. Head & Neck. 36: 1802-6. PMID 25548813 DOI: 10.1002/Hed.23536 |
0.358 |
|
| 2014 |
Cohen EE, Karrison TG, Kocherginsky M, Mueller J, Egan R, Huang CH, Brockstein BE, Agulnik MB, Mittal BB, Yunus F, Samant S, Raez LE, Mehra R, Kumar P, Ondrey F, et al. Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 2735-43. PMID 25049329 DOI: 10.1200/Jco.2013.54.6309 |
0.32 |
|
| 2014 |
Unger GM, Kren BT, Korman VL, Kimbrough TG, Vogel RI, Ondrey FG, Trembley JH, Ahmed K. Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma. Molecular Cancer Therapeutics. 13: 2018-29. PMID 24867250 DOI: 10.1158/1535-7163.Mct-14-0166 |
0.423 |
|
| 2014 |
Yang Y, Rhodus NL, Ondrey FG, Wuertz BR, Chen X, Zhu Y, Griffin TJ. Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker. Plos One. 9: e95389. PMID 24748380 DOI: 10.1371/Journal.Pone.0095389 |
0.392 |
|
| 2014 |
Sosa JA, Elisei R, Jarzab B, Balkissoon J, Lu SP, Bal C, Marur S, Gramza A, Yosef RB, Gitlitz B, Haugen BR, Ondrey F, Lu C, Karandikar SM, Khuri F, et al. Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma. Thyroid : Official Journal of the American Thyroid Association. 24: 232-40. PMID 23721245 DOI: 10.1089/Thy.2013.0078 |
0.304 |
|
| 2014 |
Seabloom D, Galbraith A, Wuertz B, Haynes A, Antonides J, fujita a, Steele V, Wattenberg L, Ondrey FG. Abstract 2140: Efficacy of aerosolized pioglitazone in lung carcinogenesis in A/J mice Cancer Research. 74: 2140-2140. DOI: 10.1158/1538-7445.Am2014-2140 |
0.336 |
|
| 2014 |
Seabloom D, Galbraith A, Haynes A, Antonides J, Fujita A, Wuertz BR, Steele V, Ondrey F, Wattenberg L. Abstract 2129: Effects of talactoferrin on lung adenoma prevention in A/J mice Cancer Research. 74: 2129-2129. DOI: 10.1158/1538-7445.Am2014-2129 |
0.333 |
|
| 2013 |
Seabloom D, Gailbraith A, Antonides J, Wuertz B, Wattenberg L, Ondrey FG. Abstract 4865: Lack of efficacy of aerosolized resveratrol on B[A]P induced pulmonary adenoma formation in A/J mice. Cancer Research. 73: 4865-4865. DOI: 10.1158/1538-7445.Am2013-4865 |
0.335 |
|
| 2012 |
Sosa JA, Balkissoon J, Lu SP, Langecker P, Elisei R, Jarzab B, Bal CS, Marur S, Gramza A, Ondrey FG. Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer Surgery. 152: 1078-1087. PMID 23158178 DOI: 10.1016/J.Surg.2012.08.036 |
0.316 |
|
| 2012 |
Wang C, Chen Q, Hamajima Y, Sun W, Zheng YQ, Hu XH, Ondrey FG, Lin JZ. Id2 regulates the proliferation of squamous cell carcinoma in vitro via the NF-κB/Cyclin D1 pathway. Chinese Journal of Cancer. 31: 430-9. PMID 22835384 DOI: 10.5732/Cjc.011.10454 |
0.356 |
|
| 2012 |
Caicedo-Granados EE, Wuertz BR, Ondrey FG. Enforced expression of nuclear factor kappa B in p53 deficient keratinocytes induces cell cycle, angiogenic potential and tumorigenesis. Oral Oncology. 48: 303-10. PMID 22143006 DOI: 10.1016/J.Oraloncology.2011.11.008 |
0.318 |
|
| 2012 |
Miller W, Wuertz B, Ondrey FG. Abstract 601: PPARδ mediated p21 induction in aerodigestive preneoplastic cell lines Cancer Research. 72: 601-601. DOI: 10.1158/1538-7445.Am2012-601 |
0.435 |
|
| 2011 |
Sosa JA, Elisei R, Jarzab B, Bal CS, Koussis H, Gramza AW, Ben-Yosef R, Gitlitz BJ, Haugen B, Karandikar SM, Khuri FR, Licitra LF, Remick SC, Marur S, Lu C, ... Ondrey FG, et al. A randomized phase II/III trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C) and paclitaxel (P) in anaplastic thyroid cancer (ATC): Final survival analysis for the FACT trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5502. PMID 28021454 DOI: 10.1200/Jco.2011.29.15_Suppl.5502 |
0.306 |
|
| 2011 |
Caicedo-Granados EE, Wuertz BR, Marker PH, Lee GS, Ondrey FG. The effect of indomethacin on paclitaxel sensitivity and apoptosis in oral squamous carcinoma cells: the role of nuclear factor-κB inhibition. Archives of Otolaryngology--Head & Neck Surgery. 137: 799-805. PMID 21844414 DOI: 10.1001/Archoto.2011.131 |
0.362 |
|
| 2011 |
Swenson WG, Wuertz BR, Ondrey FG. Tobacco carcinogen mediated up-regulation of AP-1 dependent pro-angiogenic cytokines in head and neck carcinogenesis. Molecular Carcinogenesis. 50: 668-79. PMID 21480395 DOI: 10.1002/Mc.20775 |
0.374 |
|
| 2011 |
Rosas RR, Handley NR, Gaffney PM, Wuertz BR, Ondrey FG. Abstract 1861: PPAR γ mediated involucrin induction in aerodigestive preneoplasia in vitro Cancer Research. 71: 1861-1861. DOI: 10.1158/1538-7445.Am2011-1861 |
0.428 |
|
| 2011 |
Handley NR, Gaffney PM, Taylor RS, Wuertz BR, Ondrey FG. Identification of pro-differentiation patterns by gene expression analysis following pioglitazone treatment in a primary laryngeal tumor cell line Laryngoscope. 121. DOI: 10.1002/Lary.22237 |
0.416 |
|
| 2010 |
Hamajima Y, Komori M, Preciado DA, Choo DI, Moribe K, Murakami S, Ondrey FG, Lin J. The role of inhibitor of DNA-binding (Id1) in hyperproliferation of keratinocytes: the pathological basis for middle ear cholesteatoma from chronic otitis media. Cell Proliferation. 43: 457-463. PMID 20887552 DOI: 10.1111/J.1365-2184.2010.00695.X |
0.318 |
|
| 2010 |
de Jong EP, Xie H, Onsongo G, Stone MD, Chen XB, Kooren JA, Refsland EW, Griffin RJ, Ondrey FG, Wu B, Le CT, Rhodus NL, Carlis JV, Griffin TJ. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. Plos One. 5: e11148. PMID 20567502 DOI: 10.1371/Journal.Pone.0011148 |
0.315 |
|
| 2010 |
Rohrer J, Wuertz BRK, Ondrey FG. Cigarette smoke condensate induces nuclear factor kappa-b activity and proangiogenic growth factors in aerodigestive cells. Laryngoscope. 120: 1609-1613. PMID 20564670 DOI: 10.1002/Lary.20972 |
0.386 |
|
| 2010 |
Lin J, Guan Z, Wang C, Feng L, Zheng Y, Caicedo E, Bearth E, Peng JR, Gaffney P, Ondrey FG. Inhibitor of differentiation 1 contributes to head and neck squamous cell carcinoma survival via the NF-kappaB/survivin and phosphoinositide 3-kinase/Akt signaling pathways. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 77-87. PMID 20028744 DOI: 10.1158/1078-0432.Ccr-08-2362 |
0.399 |
|
| 2010 |
Boyle JO, Ondrey FG, Brown PH, Bailey HH, Kim KM, El-Naggar AK, Szabo EM. Abstract PR-10: Randomized placebo controlled trial of pioglitazone for oral premalignant lesions: A cross-consortium collaborative study in progress Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-Pr-10 |
0.398 |
|
| 2010 |
Weidman EK, Wuertz BR, Gaffney PM, Ondrey FG. Abstract 3802: PPAR gamma mediated induction of transglutaminase in aerodigestive preneoplasia in vitro Cancer Research. 70: 3802-3802. DOI: 10.1158/1538-7445.Am10-3802 |
0.4 |
|
| 2010 |
Johnson N, Ondrey F, Wuertz B. PPARγ Mediated Transdifferentiation of Head and Neck Cancer Otolaryngology-Head and Neck Surgery. 143. DOI: 10.1016/J.Otohns.2010.06.376 |
0.351 |
|
| 2009 |
Carlson M, Wuertz B, Lin J, Taylor R, Ondrey F. Exons 19 and 21 of Epidermal Growth Factor Receptor Are Highly Conserved in Squamous Cell Cancer of the Head and Neck International Journal of Otolaryngology. 2009: 649615-649615. PMID 20130810 DOI: 10.1155/2009/649615 |
0.362 |
|
| 2009 |
Li W, Wang C, Juhn SK, Ondrey FG, Lin J. Expression of fibroblast growth factor binding protein in head and neck cancer. Archives of Otolaryngology--Head & Neck Surgery. 135: 896-901. PMID 19770422 DOI: 10.1001/Archoto.2009.121 |
0.325 |
|
| 2009 |
Ondrey F. Peroxisome Proliferator-Activated Receptor γ Pathway Targeting in Carcinogenesis: Implications for Chemoprevention Clinical Cancer Research. 15: 2-8. PMID 19118026 DOI: 10.1158/1078-0432.Ccr-08-0326 |
0.335 |
|
| 2009 |
Miller MW, Riedel G, Hoistad D, Sutherland C, Juhn SK, Adams GL, Griffin R, Ondrey FG. Ototoxicity after combined platinum and fractionated radiation in a novel guinea pig model. American Journal of Otolaryngology. 30: 1-7. PMID 19027506 DOI: 10.1016/J.Amjoto.2007.12.003 |
0.301 |
|
| 2009 |
Meyer AC, Wuertz BRK, Sidman JD, Ondrey FG. Determining the effect of imiquimod on human endothelial cells Laryngoscope. 119: S312. DOI: 10.1002/Lary.21576 |
0.347 |
|
| 2008 |
Hohberger L, Wuertz BRK, Xie H, Griffin T, Ondrey F. TNF-α drives matrix metalloproteinase-9 in squamous oral carcinogenesis Laryngoscope. 118: 1395-1399. PMID 18496150 DOI: 10.1097/Mlg.0B013E318174E09B |
0.354 |
|
| 2008 |
Papadimitrakopoulou VA, William WN, Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG, Peterson DE, Feng L, Atwell A, El-Naggar AK, Nathan CO, Helman JI, Du B, Yueh B, Boyle JO. Pilot randomized phase II study of celecoxib in oral premalignant lesions. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 2095-101. PMID 18381950 DOI: 10.1158/1078-0432.Ccr-07-4024 |
0.341 |
|
| 2007 |
Estensen RD, Anderson WR, Galbraith AR, Hartle DE, Jordan MM, Ondrey FG, Wattenberg LW. A method of producing carcinoma in upper aerodigestive tree and esophagus of the Syrian golden hamster using wounding and instillation of N-methylnitrosourea Cancer Epidemiology Biomarkers and Prevention. 16: 1644-1650. PMID 17684140 DOI: 10.1158/1055-9965.Epi-06-1075 |
0.369 |
|
| 2007 |
Janus SC, Weurtz B, Ondrey FG. Inositol hexaphosphate and paclitaxel: symbiotic treatment of oral cavity squamous cell carcinoma. The Laryngoscope. 117: 1381-8. PMID 17607147 DOI: 10.1097/Mlg.0B013E3180679E59 |
0.416 |
|
| 2007 |
Djalilian HR, Caicedo E, Lessan K, Grami V, Le CT, Spellman SR, Pambuccian S, Hall WA, Low WC, Ondrey FG. Efficacy of an osmotic pump delivered, GM-CSF-based tumor vaccine in the treatment of upper aerodigestive squamous cell carcinoma in rats. Cancer Immunology, Immunotherapy : Cii. 56: 1207-14. PMID 17219150 DOI: 10.1007/S00262-006-0271-2 |
0.356 |
|
| 2007 |
Ozeki M, Hamajima Y, Feng L, Ondrey FG, Schlentz E, Lin J. Id1 induces the proliferation of cochlear sensory epithelial cells via the nuclear factor-kappaB/cyclin D1 pathway in vitro. Journal of Neuroscience Research. 85: 515-24. PMID 17149750 DOI: 10.1002/Jnr.21133 |
0.32 |
|
| 2006 |
Patel KJ, Pambuccian SE, Ondrey FG, Adams GL, Gaffney PM. Genes associated with early development, apoptosis and cell cycle regulation define a gene expression profile of adenoid cystic carcinoma. Oral Oncology. 42: 994-1004. PMID 16762588 DOI: 10.1016/J.Oraloncology.2005.12.017 |
0.361 |
|
| 2006 |
Pearson SE, Meyer AC, Adams GL, Ondrey FG. Decreased hearing after combined modality therapy for head and neck cancer. American Journal of Otolaryngology. 27: 76-80. PMID 16500467 DOI: 10.1016/J.Amjoto.2005.07.008 |
0.333 |
|
| 2006 |
Lin J, Hamajima Y, Komori M, Feng L, Caicedo E, Adams G, Wuertz B, Ondrey F. P229 The Role of Inhibitor of Differentiation in the Angiogenesis of Head and Neck Cancers Archives of Otolaryngology-Head & Neck Surgery. 132: 910-911. DOI: 10.1001/Archotol.132.8.910-C |
0.352 |
|
| 2006 |
Carlson ML, Wuertz BR, Lin J, Adams GL, Taylor RS, Ondrey FG. P226 Lack of Exon 19 and 21 EGFR Mutations in Squamous Cell Head and Neck Cancer Specimens and Cell Lines Archives of Otolaryngology–Head & Neck Surgery. 132: 910. DOI: 10.1001/Archotol.132.8.910-A |
0.364 |
|
| 2005 |
Taylor RS, Ondrey FG. Analysis of Early Response Genes and Orphan Nuclear Receptors in Head and Neck Squamous Cell Carcinoma Otolaryngology-Head and Neck Surgery. 133. DOI: 10.1016/J.Otohns.2005.05.313 |
0.34 |
|
| 2004 |
Rusten MC, Ondrey FG. Growth inhibition and s-phase arrest in SCC cells with PPAR gamma activation Otolaryngology-Head and Neck Surgery. 131. DOI: 10.1016/J.Otohns.2004.06.319 |
0.398 |
|
| 2004 |
Vo-Nguyen TT, Ondrey FG. The effect of EGF receptor inhibition on NF kappa b activation in oral cancer cells Otolaryngology-Head and Neck Surgery. 131: 177. DOI: 10.1016/J.Otohns.2004.06.318 |
0.413 |
|
| 1999 |
Li W, Lin J, Juhn SK, Ondrey FG, Adams GL. Expression of FGF-BP in squamous cancer of the head and neck * Otolaryngology-Head and Neck Surgery. 121: 86. DOI: 10.1016/S0194-5998(99)80106-5 |
0.354 |
|
| Show low-probability matches. |